Autologous hematopoietic stem cell transplantation (AHSCT) as consolidation therapy for childhood acute myelogenous leukemia in 1st complete remission [2]

Pediatric Hematology and Oncology

Volumn 18, Issue 5, 2001, Pages 359-362

  Biagi, E ^a   Rovelli, A ^a   De Lorenzo, P ^a   Uderzo, C ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Acute myelogenous leukemia; Autologous bone marrow transplantation

Indexed keywords

CYTARABINE; DEXAMETHASONE; ETOPOSIDE; IDARUBICIN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; LETTER; LEUKEMIA REMISSION; MALE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034930368     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800101300312654     Document Type: Letter

References (6)

1. Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87
2. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group
3. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: Results of the United Kingdom Medical Research Council's 10th AML trial
4. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission
5. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission
6. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide